Home Detection of CYP2D6*3 and 2D6*4 Allelic Variants by PCR-Restriction Fragment Length Polymorphism
Article
Licensed
Unlicensed Requires Authentication

Detection of CYP2D6*3 and 2D6*4 Allelic Variants by PCR-Restriction Fragment Length Polymorphism

  • Elizabeta Topić , Mario Štefanović , Vjeran Nikolić , Ivan Zoričić , Ana-Maria Ivanišević and Irena Žuntar
Published/Copyright: June 1, 2005
Become an author with De Gruyter Brill
Clinical Chemistry and Laboratory Medicine (CCLM)
From the journal Volume 36 Issue 8

Abstract

The mutant of CYP2D6*3 allele with A2637 deletion in exon 5 and the mutant of CYP2D6*4 allele G1934→A, splice site defect are among the most common polymorphic alleles of CYP2D6 gene, resulting in a decreased or no activity of CYP isoenzyme. In this study, a reliable polymerase chain reaction-restriction fragment length polymorphism method for identification of CYP2D6*3 and CYP2D6*4 alleles was used to investigate the genotype and phenotype prevalence in the groups of normal controls, and of cirrhosis and cancer patients. The results showed none of 36 controls genotyped for 2D6*3 and 2D6*4 allele to have the 2D6*3 allele with frameshift mutation in exon 5, while 33 % (n=12) were found to bear the 2D6*4 allele with G to A mutation at the intron 3—exon 4 junction. In breast cancer patients (n=35) genotyped for 2D6*3 and 2D6*4 alleles, none with 2D6*3 allele was found either, but 60 % (n=18) were found to bear the 2D6*4 allele. In patients with head and neck squamous cell cancer, there was only one subject with 2D6*3 allele and he was heterozygous. Among them, as many as ten (40 %) patients were found to bear 2D6*4 allele. In the cirrhosis group, none of the patients was found to have the 2D6*3 allele, while the CYP2D6*4 allele was found in 23 % (n=6) patients. The phenotype predicted according to the genotype was as follows: in the control group, 3% of individuals were identified as poor metabolizers, 70 % as extensive metabolizers, and 27 % as heterozygote extensive metabolizers. In the group of breast cancer, 7% of the patients were identified as poor metabolizer, 57 % as extensive metabolizer and 36% as phenotype. In squamous cell cancer and cirrhosis patients, the incidence of poor metabolizer was zero, and of heterozygotes extensive metabolizer 42 % and 31 %, respectively.

:
Published Online: 2005-06-01
Published in Print: 1998-08-01

Copyright © 1999 by Walter de Gruyter GmbH & Co. KG

Articles in the same Issue

  1. Human Genomics: The Basis of the Medicine of Tomorrow. Recent Progress in Molecular Biology Technology. First IFCC-Roche Conference – Singapore, 15–18 March 1998
  2. Does Clinical Chemistry Have a Future?
  3. The Human Genome Project: From Mapping to Sequencing
  4. The Human Genome Project and the Role of Genetics in Health Care
  5. Mutation Detection and Mutation Databases
  6. Population Genomics: Laying the Groundwork for Genetic Disease Modeling and Targeting
  7. Oligonucleotide-Based Gene Therapy for Cardiovascular Disease
  8. Signal Transduction Pathways and Modulation of Gene Activity
  9. Do Overexpressed Oncoproteins Cause Malignant Growth of Cancer Cells? – Studied by Antisense Oligonucleotides
  10. Ethical and Legal Issues in the Procurement, Storage and Use of DNA
  11. DNA Extraction and Stability for Epidemiological Studies
  12. Simple and Broadly Applicable Sample Preparation by Use of Magnetic Glass Particles
  13. A Multilocus Genotyping Assay for Cardiovascular Disease
  14. Optimized Non-Radioactive Protein Truncation Test for Mutation Analysis of the Adenomatous Polyposis Coli (APC) Gene
  15. Monitoring of Inhibitors of Enzymatic Amplification in Polymerase Chain Reaction and Evaluation of Efficacy of RNA Extraction for the Detection of Hepatitis C Virus Using the Internal Control
  16. Quantification of Relative Expression of Genes with Homologous Sequences Using Fluorescence-Based Single-Strand Conformation Polymorphism Analysis – Application to Lactate Dehydrogenase and Cyclooxygenase Isozymes
  17. Automation of Polymerase Chain Reaction-Based Systems for Detection of Hepatitis C Virus RNA
  18. A Simple PCR with Different 3′ Ends of the Third Primer for Detection of Defined Point Mutations: HCV Genotyping as an Example
  19. Two Quantitative Methods for Imaging Samples in Molecular Biology
  20. Restriction Digest PCR (RD-PCR) for the Analysis of Gene Mutations. Application to Ki-ras
  21. Direct Detection of Mycobacterium tuberculosis in Respiratory Specimens Using an Automated DNA Amplification Assay and a Single Tube Nested Polymerase Chain Reaction (PCR)
  22. Quantitative Detection of Hepatitis B Virus DNA with a New PCR Assay
  23. Molecular Diagnostics for Cardiovascular Disease
  24. Association of Apolipoprotein E Polymorphism and Concentration with Serum Lipids and Apo-lipoprotein Level in the Chinese fromShanghai
  25. Angiotensin Converting Enzyme Gene Polymorphism in Coronary Artery Disease: The Indian Scenario
  26. Mutation C677T of Methylenetetrahydrofolate Reductase Gene Is Not Associated with Coronary Artery Disease, but Possibly with Albuminuria, in Type 2 Diabetic Patients
  27. Cholesteryl Ester Transfer Protein Mutations, Protein Activity and HDL-Cholesterol Concentration
  28. Molecular Biology of Alcohol Dependence, a Complex Polygenic Disorder
  29. Analysis of Clonality in T-Lymphoproliferative Diseases by Multiplex PCR
  30. The Impact of Molecular Diagnosis on Familial Colorectal Cancer
  31. Screening for Tumour Suppressor p16(CDKN2A) Germline Mutations in Israeli Melanoma Families
  32. CGG Repeat Interruptions in the FMR1 Gene in Patients with Infantile Autism
  33. Detection of CYP2D6*3 and 2D6*4 Allelic Variants by PCR-Restriction Fragment Length Polymorphism
  34. Genetic Basis of Congenital Hypothyroidism: Abnormalities in the TSHβ Gene, the PIT1 Gene, and the NIS Gene
  35. Follitropin (FSH) Deficiency in an Infertile Male due to FSHβ Gene Mutation. A Syndrome of Normal Puberty and Virilization but Under-developed Testicles with Azoospermia, Low FSH but High Lutropin and Normal Serum Testosterone Concentrations
  36. Molecular Analysis and Electromyoneurographic Abnormalities in Croatian Children with Proximal Spinal Muscular Atrophies
Downloaded on 10.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/CCLM.1998.116/pdf
Scroll to top button